Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsPrice Target
Deutsche Bank analyst Omotayo Okusanya maintains National Health Investors (NYSE:NHI) with a Hold and lowers the price target from $85 to $80.
Deutsche Bank analyst Omotayo Okusanya maintains National Health Investors (NYSE:NHI) with a Hold and lowers the price target from $85 to $80.